- Availability of independent end-user reviews for HDIS
- Gartner Peer Insights / G2 / TrustRadius
- No readily accessible product review pages were found for “Harris Data Integrity Solutions,” “CuraMatch,” or “SmartIX” on Gartner Peer Insights, G2, or TrustRadius during this research.
- Some review platforms can be difficult to search without exact product listings; however, multiple targeted searches did not surface HDIS profiles.
- Practical implication
- Buyers may need to rely more on:
- Reference calls provided by HDIS
- Conference peer networks (AHIMA, HIMSS)
- Proof-of-concept validation and internal benchmarking
- Vendor/partner-published testimonials and case claims (not independently verified)
- RightPatient site includes attributed testimonial quotes such as:
- “One of the reasons we selected RightPatient at Novant Health was that it supports any type of biometrics and device…” (attributed to a revenue cycle VP; note: the quote appears on RightPatient marketing pages).
- “RightPatient® was a perfect fit for us… runs flawlessly over Citrix.” (attributed to an AVP of revenue cycle).
- RightPatient blog case content claims outcomes including:
- Vendor-published claims of a notable reduction in chart corrections and very high patient acceptance with many patients enrolled for a named organization, presented as a testimonial/case story.
- Important caveat
- These are vendor/partner marketing claims rather than neutral review-platform feedback.
- Community/Social (Reddit, etc.) signal quality
- Searches for HDIS-specific community discussion surfaced mostly unrelated “Harris” matches (e.g., discussions about a health system breach) rather than product usage experiences.
- Why customers chose this product over alternatives (inferred from vendor messaging)
- To replace manual spreadsheet workflows and reduce HIM backlog via automation.
- To operate EHR-agnostically rather than relying on embedded EHR matching.
- To reduce costs relative to “traditional EMPI” investments (vendor claim).
- Why some customers left for competitors (churn reasons)
- Not documented in public reviews for HDIS; competitor case studies provide indirect competitive narratives (see Competitive Landscape).
- HDIS / CuraMatch / Intelligent MPI Triage case-style claims
- Intelligent MPI Triage page includes an “outcome snapshot” graphic and claims such as:
- “Experience a significant reduction in the amount of time it takes your team to work down potential duplicates.”
- A specific example graphic references a substantial reduction in duplicate pairs in a short timeframe from a large backlog (presented on-page; methodology and customer identity not shown on the captured excerpt).
- Critical evaluation
- These are vendor-published metrics with limited disclosed methodology (e.g., baseline definitions, measurement window, what counts as “duplicate pairs,” false positive/negative impact, downstream clinical outcomes).
- CuraMatch cost-reduction claim
- HDIS claims CuraMatch “can reduce overall costs by a substantial percentage compared to other alternatives” and repeats this theme in both product pages and third-party coverage.
- Critical evaluation
- The claim is not accompanied by a publicly available TCO model, sample customer cost breakdown, or independent validation.
- External/third-party coverage with case-like statements
- CIOReview profile repeats HDIS claims:
- CuraMatch identifies “more true duplicates” than embedded tools, and SmartIX achieves a very high accuracy rate (as stated in the article).
- Critical evaluation
- CIOReview content may be promotional/advertorial in nature; buyers should treat these as vendor-aligned narratives unless backed by independent research and transparent testing methods.
- RightPatient (partner) case studies and outcomes
- RightPatient marketing content claims usage scale (a large number of sites and a high annual patient visit volume on one page; other pages claim protection of millions of patient identities).
- RightPatient also provides a public blog/case-style write-up citing outcomes such as a notable decline in chart corrections (third-party press coverage) and a testimonial post citing a double-digit reduction in chart corrections and very high patient acceptance.
- Critical evaluation
- These metrics are primarily from vendor marketing and PR; they may be directionally useful but should be validated via direct customer references and internal KPI baselining.